4//SEC Filing
Kharabi Darius 4
Accession 0001415889-23-004978
CIK 0001479419other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 8:00 PM ET
Size
6.0 KB
Accession
0001415889-23-004978
Insider Transaction Report
Form 4
Kharabi Darius
CHIEF BUSINESS OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2023-03-14+432→ 432 totalExercise: $68.50Exp: 2032-01-03→ Common Stock (432 underlying)
Footnotes (2)
- [F1]On January 3, 2022, the Reporting Person was granted an option to purchase up to 1,620 shares of common stock of the Issuer. Specified portions of the options vest based on the level of achievement of specified performance metrics relating to financial, operational and scientific matters.
- [F2]On March 14, 2023, the Compensation Committee of the Issuer's Board of Directors determined that certain of the performance conditions were achieved at specific levels of achievement, resulting in vesting of the option as to 432 shares of common stock. The Compensation Committee has made no determination with respect to certain performance metrics, which could result in the further vesting of up to 324 shares of common stock underlying the option.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001893729
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 8:00 PM ET
- Size
- 6.0 KB